Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression

  • Toll Abelló, Agustí|||0000-0003-2656-0076
  • Salgado Sánchez, Rocío Nieves|||0000-0003-1678-8982
  • Espinet Solà, Blanca|||0000-0002-4294-8145
  • Diaz-Lagares, Angel|||0000-0002-9114-9227
  • Hernández-Ruiz, Eugenia
  • Andrades, Evelyn|||0000-0003-2166-6760
  • Sandoval, Juan|||0000-0002-5100-973X
  • Esteller, M.|||0000-0003-4490-6093
  • Pujol, Ramón M..
  • Hernández-Muñoz, Inmaculada
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer and frequently progresses from an actinic keratosis (AK), a sun-induced keratinocyte intraepithelial neoplasia (KIN). Epigenetic mechanisms involved in the phenomenon of progression from AK to cSCC remain to be elicited. Expression of microRNAs in sun-exposed skin, AK and cSCC was analysed by Agilent microarrays. DNA methylation of miR-204 promoter was determined by bisulphite treatment and pyrosequencing. Identification of miR-204 targets and pathways was accomplished in HaCat cells. Immunofluorescence and immunohistochemistry were used to analyze STAT3 activation and PTPN11 expression in human biopsies. cSCCs display a marked downregulation of miR-204 expression when compared to AK. DNA methylation of miR-204 promoter was identified as one of the repressive mechanisms that accounts for miR-204 silencing in cSCC. In HaCaT cells miR-204 inhibits STAT3 and favours the MAPK signaling pathway, likely acting through PTPN11, a nuclear tyrosine phosphatase that is a direct miR-204 target. In non-peritumoral AK lesions, activated STAT3, as detected by pY705-STAT3 immunofluorescence, is retained in the membrane and cytoplasm compartments, whereas AK lesions adjacent to cSCCs display activated STAT3 in the nuclei. Our data suggest that miR-204 may act as a "rheostat" that controls the signalling towards the MAPK pathway or the STAT3 pathway in the progression from AK to cSCC. The online version of this article (doi:10.1186/s12943-016-0537-z) contains supplementary material, which is available to authorized users.